Search for: "United States v. United States Gypsum Company" Results 1 - 20 of 28
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2022, 8:38 am by Paul Pryzant and Matthew Simmons
 The Non-Competition Covenant prohibited Adams from competing anywhere in the states of Idaho and Washington, and within a 100 mile radius of any other location outside of those states in which Kodiak or any of its operating units had sold products or services in the 12 months prior to closing. [read post]
20 Feb 2019, 2:13 pm by admin
He received his Bachelor of Arts degree from Michigan State University in 1968 and his Masters degree from Michigan State University in 1971. [read post]
15 Feb 2019, 6:41 am by Law Offices of Jeffrey S. Glassman
When it comes to providing care to mesothelioma patients and protecting consumers from the risks of asbestos exposure, the United States lags significantly behind effort in the United Kingdom. [read post]
19 Nov 2017, 4:36 am by Mark Summerfield
  This change from the old ‘fair basis’ provision was intended to align Australian patent law with that of the UK and Europe, requiring the disclosure to be commensurate with the scope of the claims, i.e. that the description should be sufficient to enable the skilled person to perform the invention across the full width of the claims.So far, there has been no judicial consideration of this new enablement requirement, and until recently there was just one Patent Office decision, CSR… [read post]
2 Feb 2017, 6:40 am
Agriculture and Nutrition, LLC Industries $901 million United States Gypsum $3.9 billion Leslie Controls n.a. [read post]
23 Jan 2016, 11:42 pm by Mark Summerfield
Back in November 2015, the Australian Patent Office issued the first published decision to consider enhanced requirements for patent specifications that were introduced by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012: CSR Building Products Limited v United States Gypsum Company [2015] APO 72.The decision arises from an opposition by CSR Building Products Limited to the grant of a patent on an application by United… [read post]
25 Apr 2015, 11:03 am by Schachtman
Third, the Manual authors state that the doubling argument assumes the “[n]onacceleration of disease. [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]